Sector: MedicalThreshold Pharmaceuticals, Inc. (NASDAQ: THLD)
Headlines
- Threshold Pharmaceuticals Presents Interim Prostate Cancer Data From Early Stage Trials of TH-302
Nov 18, 2009 08:46 AM | THLD
- Threshold to Present at Lazard Capital Markets Healthcare Conference
Nov 16, 2009 08:26 AM | THLD
- Threshold Pharmaceuticals Announces Clinical Development Results for Cancer Candidate TH-302
Nov 12, 2009 04:02 PM | THLD
- Threshold Pharmaceuticals Presents Interim Data From a Phase 1/2 Clinical Trial of TH-302 at Sarcoma Meeting
Nov 06, 2009 08:46 AM | THLD
- Threshold Pharmaceuticals Reports Third Quarter 2009 Financial Results
Nov 05, 2009 04:04 PM | THLD
- Threshold Pharmaceuticals Licenses Glufosfamide to Eleison Pharmaceuticals
Oct 15, 2009 08:32 AM | THLD
- 11 Cheap Stocks To Trade : Oct 13, 2009
Oct 13, 2009 01:55 PM | BBBY, IMGG, RODM, THLD
- Threshold Pharmaceuticals Presents Interim Data From a Phase 1/2 Clinical Trial of TH-302 At Melanoma Conference
Oct 08, 2009 04:01 PM | THLD
- Threshold Pharmaceuticals Completes $35 Million Private Equity Financing
Oct 06, 2009 08:25 AM | THLD
- Threshold Pharmaceuticals Provides Clinical Trial Update From a Complete Phase 1/2 Clinical Trial of TH-302 in Combination With Chemotherapy
Sep 21, 2009 08:46 AM | THLD
- Threshold Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 06, 2009 04:05 PM | THLD
- Results From TH-302 Clinical Trials Presented at International Lung Cancer Meeting
Aug 04, 2009 04:06 PM | THLD
- Threshold Pharmaceuticals ASCO Webcast Available On Company Website
Jun 08, 2009 04:00 PM | THLD
- Threshold Pharmaceuticals Presents Encouraging Data From Clinical Trials of TH-302 for Solid Tumors
Jun 01, 2009 08:00 AM | THLD
- Threshold Pharmaceuticals Presents Encouraging Data From Clinical Trials of TH-302 for Solid Tumors
May 30, 2009 08:01 AM | THLD
- Threshold Pharmaceuticals Announces a Presentation At the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
May 27, 2009 08:46 AM | THLD
- Threshold Pharmaceuticals Reports First Quarter 2009 Financial Results
May 07, 2009 08:35 AM | THLD
- Threshold Pharmaceuticals Presents Positive TH-302 Preclinical Results in Three Scientific Presentations At AACR Annual Meeting
Apr 20, 2009 08:25 AM | THLD
- Threshold Pharmaceuticals Announces Multiple Presentations at the 2009 American Association for Cancer Research (AACR) Annual Meeting
Apr 14, 2009 09:02 AM | THLD
- Threshold Pharmaceuticals Announces Going Concern Opinion
Mar 19, 2009 08:30 AM | THLD
- Form 4 Curd John G For: Nov 02 (10K)
Nov 04, 2009 02:56 PM
- Form 3 THRESHOLD PHARMACEUTICAL For: Oct 05 Filed by: FHM VI, L.L.C. (10K)
Oct 15, 2009 06:12 PM
- Form 4 THRESHOLD PHARMACEUTICAL For: Oct 05 Filed by: JAEGER WILFRED E (10K)
Oct 07, 2009 10:31 PM
- Form 4 LITTLECHILD JOHN W For: Oct 05 (10K)
Oct 07, 2009 07:15 PM
- Form 4 YOUNGER WILLIAM H JR For: Oct 05 (10K)
Oct 07, 2009 06:57 PM
- Form 4 WHITE JAMES N For: Oct 05 (10K)
Oct 07, 2009 06:56 PM
- Form 4 SWEET DAVID E For: Oct 05 (10K)
Oct 07, 2009 06:44 PM
- Form 4 THRESHOLD PHARMACEUTICAL For: Oct 05 Filed by: SHEEHAN ANDREW T (10K)
Oct 07, 2009 06:42 PM
- Form 4 SANDS GREGORY P For: Oct 05 (10K)
Oct 07, 2009 06:41 PM
- Form 4 GAITHER JAMES C For: Oct 05 (10K)
Oct 07, 2009 06:40 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
THLD
|
Compare to S&P
|
| YTD |
256.14 %
|
194.75 %
|
| 4 Weeks |
-33.44 %
|
-34.16 %
|
| 12 Weeks |
49.26 %
|
40.72 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 2.44 %
|
|
EPS Growth in Last Year: 16.67 %
|
|
Sales Growth in Last Quarter: -0.55 %
|
|
Sales Growth in Last Quarter: 0.28 %
|
|
